Profile | GDS5420 / 226754_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 578.47 | 70 |
GSM1296119 | B_lesional_pre-dose | 344.48 | 61 |
GSM1296076 | C_lesional_pre-dose | 207.52 | 55 |
GSM1296092 | D_lesional_pre-dose | 151.66 | 50 |
GSM1296103 | E_lesional_pre-dose | 341.94 | 61 |
GSM1296078 | F_lesional_pre-dose | 193.9 | 54 |
GSM1296107 | G_lesional_pre-dose | 256.44 | 56 |
GSM1296109 | H_lesional_pre-dose | 280.32 | 57 |
GSM1296080 | I_lesional_pre-dose | 809.05 | 75 |
GSM1296090 | J_lesional_pre-dose | 229.96 | 56 |
GSM1296074 | K_lesional_pre-dose | 272.32 | 59 |
GSM1296111 | L_lesional_pre-dose | 218.7 | 53 |
GSM1296099 | M_lesional_pre-dose | 431.47 | 65 |
GSM1296086 | O_lesional_pre-dose | 214.66 | 55 |
GSM1296117 | P_lesional_pre-dose | 250.03 | 55 |
GSM1296113 | Q_lesional_pre-dose | 234.8 | 53 |
GSM1296096 | R_lesional_pre-dose | 451.64 | 66 |
GSM1296105 | S_lesional_pre-dose | 616.78 | 71 |
GSM1296098 | T_lesional_pre-dose | 652.76 | 72 |
GSM1296101 | U_lesional_pre-dose | 450.26 | 65 |
GSM1296121 | V_lesional_pre-dose | 362.42 | 62 |
GSM1296088 | W_lesional_pre-dose | 323.39 | 61 |
GSM1296082 | X_lesional_pre-dose | 109.85 | 45 |
GSM1296115 | Y_lesional_pre-dose | 241.14 | 55 |
GSM1296084 | Z_lesional_pre-dose | 416.23 | 65 |
GSM1296072 | B_lesional_day8 | 402.49 | 64 |
GSM1296069 | L_lesional_day8 | 328.32 | 60 |
GSM1296071 | P_lesional_day8 | 527.81 | 68 |
GSM1296070 | Y_lesional_day8 | 342.89 | 60 |
GSM1296073 | V_lesional_day8 | 191.29 | 52 |
GSM1296034 | A_lesional_day15 | 1293.59 | 84 |
GSM1296041 | G_lesional_day15 | 247.71 | 56 |
GSM1296035 | R_lesional_day15 | 463.6 | 66 |
GSM1296038 | U_lesional_day15 | 307.96 | 59 |
GSM1296047 | B_lesional_day15 | 469.82 | 66 |
GSM1296039 | E_lesional_day15 | 294.69 | 59 |
GSM1296042 | H_lesional_day15 | 332.47 | 60 |
GSM1296043 | L_lesional_day15 | 369.62 | 62 |
GSM1296037 | M_lesional_day15 | 600.77 | 71 |
GSM1296046 | P_lesional_day15 | 472.86 | 66 |
GSM1296044 | Q_lesional_day15 | 349.86 | 61 |
GSM1296045 | Y_lesional_day15 | 330.23 | 60 |
GSM1296025 | C_lesional_day15 | 1178.83 | 81 |
GSM1296033 | D_lesional_day15 | 487.48 | 67 |
GSM1296027 | I_lesional_day15 | 583.94 | 70 |
GSM1296032 | J_lesional_day15 | 693.28 | 73 |
GSM1296024 | K_lesional_day15 | 1337.99 | 83 |
GSM1296031 | W_lesional_day15 | 443.11 | 65 |
GSM1296028 | X_lesional_day15 | 488.45 | 67 |
GSM1296029 | Z_lesional_day15 | 659.05 | 72 |
GSM1296026 | F_lesional_day15 | 637.94 | 72 |
GSM1296030 | O_lesional_day15 | 477.71 | 67 |
GSM1296040 | S_lesional_day15 | 512.16 | 68 |
GSM1296036 | T_lesional_day15 | 686.64 | 73 |
GSM1296048 | V_lesional_day15 | 375.58 | 63 |
GSM1296059 | A_lesional_day43 | 453 | 66 |
GSM1296066 | G_lesional_day43 | 305.21 | 59 |
GSM1296060 | R_lesional_day43 | 558.44 | 69 |
GSM1296063 | U_lesional_day43 | 305.77 | 59 |
GSM1296064 | E_lesional_day43 | 281.99 | 59 |
GSM1296067 | H_lesional_day43 | 684.3 | 73 |
GSM1296062 | M_lesional_day43 | 671.37 | 72 |
GSM1296068 | Q_lesional_day43 | 388.66 | 62 |
GSM1296050 | C_lesional_day43 | 542.37 | 69 |
GSM1296057 | D_lesional_day43 | 522.43 | 68 |
GSM1296052 | I_lesional_day43 | 521.49 | 69 |
GSM1296054 | J_lesional_day43 | 737.13 | 74 |
GSM1296049 | K_lesional_day43 | 1172.31 | 81 |
GSM1296055 | W_lesional_day43 | 392.06 | 63 |
GSM1296053 | X_lesional_day43 | 596.58 | 70 |
GSM1296058 | Z_lesional_day43 | 558.82 | 69 |
GSM1296051 | F_lesional_day43 | 397.06 | 65 |
GSM1296056 | O_lesional_day43 | 325.74 | 61 |
GSM1296065 | S_lesional_day43 | 450.67 | 66 |
GSM1296061 | T_lesional_day43 | 1010.5 | 79 |
GSM1296095 | A_non-lesional_pre-dose | 418.72 | 65 |
GSM1296120 | B_non-lesional_pre-dose | 424.24 | 65 |
GSM1296077 | C_non-lesional_pre-dose | 774.23 | 75 |
GSM1296093 | D_non-lesional_pre-dose | 926.2 | 78 |
GSM1296104 | E_non-lesional_pre-dose | 260.42 | 57 |
GSM1296079 | F_non-lesional_pre-dose | 782.2 | 75 |
GSM1296108 | G_non-lesional_pre-dose | 296.33 | 58 |
GSM1296110 | H_non-lesional_pre-dose | 462.29 | 66 |
GSM1296081 | I_non-lesional_pre-dose | 767.37 | 75 |
GSM1296091 | J_non-lesional_pre-dose | 277.54 | 58 |
GSM1296075 | K_non-lesional_pre-dose | 445.09 | 67 |
GSM1296112 | L_non-lesional_pre-dose | 394.68 | 63 |
GSM1296100 | M_non-lesional_pre-dose | 739.72 | 74 |
GSM1296087 | O_non-lesional_pre-dose | 381.28 | 64 |
GSM1296118 | P_non-lesional_pre-dose | 495.55 | 67 |
GSM1296114 | Q_non-lesional_pre-dose | 273.21 | 56 |
GSM1296097 | R_non-lesional_pre-dose | 634.43 | 72 |
GSM1296106 | S_non-lesional_pre-dose | 559.73 | 69 |
GSM1296102 | U_non-lesional_pre-dose | 691.9 | 73 |
GSM1296122 | V_non-lesional_pre-dose | 749.1 | 75 |
GSM1296089 | W_non-lesional_pre-dose | 358.64 | 61 |
GSM1296083 | X_non-lesional_pre-dose | 1045.23 | 80 |
GSM1296116 | Y_non-lesional_pre-dose | 372.72 | 62 |
GSM1296085 | Z_non-lesional_pre-dose | 647.99 | 72 |